The efficacy and side effects of oxytocin, methyl ergonovine (metergin) and misoprostol in the excretion of pregnancy products.
Phase 3
Recruiting
- Conditions
- incomplete abortion in first trimester.Incomplete spontaneous abortion without complicationO03.4
- Registration Number
- IRCT20200122046221N1
- Lead Sponsor
- Jahrom University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 90
Inclusion Criteria
tendency toward outpatient treatment
gestational age less than 14 week
not presence of high risk disease
Exclusion Criteria
presence of a major disease
the patients who can not tolerate drugs
those who get tired from the process of treatment
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Time of disposal of pregnancy products. Timepoint: Before starting the study . 3-6-9 days after starting the drug regimen. Method of measurement: The time from partial abortion to complete disposal of pregnancy products was measured.
- Secondary Outcome Measures
Name Time Method